Skip to main content
Journal cover image

Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.

Publication ,  Journal Article
Orloff, DG; Blazing, MA; O'Connor, CM
Published in: Am Heart J
November 1999

Duke Scholars

Published In

Am Heart J

DOI

ISSN

0002-8703

Publication Date

November 1999

Volume

138

Issue

5 Pt 1

Start / End Page

S406 / S412

Location

United States

Related Subject Headings

  • Risk Factors
  • Lipids
  • Hypolipidemic Agents
  • Hypoglycemic Agents
  • Hyperlipidemias
  • Humans
  • Drug Therapy, Combination
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Blood Glucose
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Orloff, D. G., Blazing, M. A., & O’Connor, C. M. (1999). Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies. Am Heart J, 138(5 Pt 1), S406–S412. https://doi.org/10.1016/s0002-8703(99)70043-8
Orloff, D. G., M. A. Blazing, and C. M. O’Connor. “Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.Am Heart J 138, no. 5 Pt 1 (November 1999): S406–12. https://doi.org/10.1016/s0002-8703(99)70043-8.
Orloff, D. G., et al. “Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.Am Heart J, vol. 138, no. 5 Pt 1, Nov. 1999, pp. S406–12. Pubmed, doi:10.1016/s0002-8703(99)70043-8.
Journal cover image

Published In

Am Heart J

DOI

ISSN

0002-8703

Publication Date

November 1999

Volume

138

Issue

5 Pt 1

Start / End Page

S406 / S412

Location

United States

Related Subject Headings

  • Risk Factors
  • Lipids
  • Hypolipidemic Agents
  • Hypoglycemic Agents
  • Hyperlipidemias
  • Humans
  • Drug Therapy, Combination
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Blood Glucose